Japfa Comfeed Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Japfa Comfeed Indonesia Tbk. trades at Rp2,030 (market cap 23.8T, 8.44M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Japfa Comfeed Indonesia Tbk. is far larger — about 35.1× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.57M versus 8.44M). Which is the better fit depends on your goals.
| JPFA | RSCH | |
|---|---|---|
Market Cap | 23.8T | 678.4B |
Volume | 8.44M | 25.57M |
Lot | 84.36K | 255.67K |
Turnover | 17.08B | 6.57B |
Average Price | 2,024.41 | 256.8 |
Value | 17.08B | 6.57B |
Indicative Equilibrium Price | 2,030 | 258 |
Indicative Equilibrium Volume | 3.58K | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Read more on JPFA →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →